Table 7.

Result of CSNI treatments with 1% compounded budesonide drops and betamethasone cream.

Types of CSNI		Treatment cycle						Test	p-Value
		1% Budesonide		Betamethasone		Total
		n = 149		n = 143		n = 292
Treatment time (days)	M/SD	158.4	111.8	142.7	81.1	150.7	98.4	T	0.17
Subjective improvement	n (%)	123	82.6	118	82.5	241	82.5	Chi	1.00
Pre-treatment SNOT-22	M/SD	31.8	22.3	33.9	25.1	32.8	23.8	T	0.45
Post-treatment SNOT-22	M/SD	29.6	22.7	32.8	26.8	31.2	24.9	T	0.26
		Pre-post T	0.09	Pre-post T	0.21	Pre-post T	0.06
Pre-treatment total LKES	M/SD	5.1	3.1	4.4	2.9	4.8	3.0	T	0.04a
Post-treatment total LKES	M/SD	4.6	3.2	4.2	3.2	4.4	3.2	T	0.28
		Pre-post T	0.02a	Pre-post T	0.19	Pre-post T	0.01a
Adverse events	n (%)	0	0.0	7	4.9	7	2.4	Fisher	0.006a
Exacerbations	n (%)	13	8.7	6	4.2	19	6.5	Fisher	0.12
Need for subsequent surgery	n (%)	13	8.7	20	14.0	33	11.3	Chi	0.16

Chi, Chi-square test; CSNI, corticosteroid nasal irrigation; CSNS, Topical corticosteroid nasal spray; Fisher, Fisher exact test; M, mean; SD, standard deviation; n, number; %, percentage; LKES, Lund–Kennedy endoscopic score; SNOT-22 (BR), SinoNasal Outcome Test-22 in Brazilian Portuguese; T, T-test.

^ap < 0.05.